Main Ideas:
– Clinical trials could face delays which might lead to extended timelines for new drug approvals.
– A sudden reduction in financial support could result in the loss of critical data if research teams disband before completing studies.
Author’s Take:
Potential delays in clinical trials and financial cuts pose significant threats to the progress of research organizations. It is imperative for these organizations to consider alternative strategies to sustain their work and ensure the continuity of vital research efforts.
Click here for the original article.